Literature DB >> 10023358

Reproductive tract infections in primary healthcare, family planning, and dermatovenereology clinics: evaluation of syndromic management in Morocco.

C A Ryan1, A Zidouh, L E Manhart, R Selka, M Xia, M Moloney-Kitts, J Mahjour, M Krone, B N Courtois, G Dallabetta, K K Holmes.   

Abstract

OBJECTIVE: To determine where and with what symptoms women seek care for reproductive tract infections (RTI) in Morocco and to guide allocation of resources for training and treatment for RTIs.
METHODS: A primary healthcare centre (PHC), a family planning centre (FPC), and a specialty dermatovenereology clinic (SC) were selected in each of three urban areas. Women with symptoms of vaginal discharge, lower abdominal or pelvic pain, or genital lesions (genital ulcer or warts) underwent interviews, physical examinations, serological testing for human immunodeficiency virus (HIV) and syphilis, and collection of vaginal fluid for microscopic examination, and urine for detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) by ligase chain reaction (LCR).
RESULTS: Over 8 months, 1238 women enrolled, including 61.8% at PHCs, 34.8% at FPCs, and 3.4% at SCs. Overall, 54% complained of vaginal discharge, of whom 8.8% had GC or CT infection and 30.1% had trichomoniasis (TV) or bacterial vaginosis (BV); 24.9% complained of lower abdominal pain with or without vaginal discharge, of whom 7.3% had GC or CT and 22.6% had TV or BV. GC or CT infections were found in 10.1% of PHC and 5.4% of FPC patients; while TV and/or BV infections were found in 28.7% and 22.8%, respectively. GC or CT infection was associated with perceived risk behaviours of the male partner (for example, belief partner is unfaithful) more often than with reported risk behaviours of the women themselves. For vaginal infections, a modified World Health Organisation (WHO) test algorithm for vaginal discharge involving risk assessment plus speculum and bimanual examination was 98.0% sensitive at PHCs and 90.8% at FPCs, with positive predictive value (PPV) of 33.4% at PHCs and 26.8% at FPCs. For GC or CT infections this algorithm was 60.6% sensitive at PHCs and 85.7% sensitive at FPCs; but PPV was only 9.9% and 9.0% respectively, little higher than the background prevalence of these infections. An RTI algorithm (Morocco specific) had comparable sensitivity and PPV for vaginal infection, and for cervical infection was less sensitive but had much higher PPV (26.9% for PHCs and 26.7% for FPCs).
CONCLUSION: Women with complaints of vaginal discharge and/or lower abdominal pain presented to PHC and FP clinics, not to SCs. PHCs and FPCs should therefore receive resources for management of vaginal discharge. Both the test algorithm and the new RTI algorithm were useful in allocating treatment for vaginal infection, but only the RTI algorithm discriminated in selecting women with cervical infection. Even with the RTI algorithm, which limited treatment for cervical infection to risk assessment positive patients with signs of cervical infection or PID, the PPV for cervical infection was low, potentially resulting in frequent overtreatment and problems of partner notification.

Entities:  

Mesh:

Year:  1998        PMID: 10023358

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  7 in total

1.  Study to Evaluate Targeted Management and Syndromic Management in Women Presenting with Abnormal Vaginal Discharge.

Authors:  Veena Meena; Charu Lata Bansal
Journal:  J Obstet Gynaecol India       Date:  2016-04-29

2.  Nucleic acid amplification tests (NAATs) for gonorrhoea diagnosis in women: experience of a tertiary care hospital in north India.

Authors:  Seema Sood; Rachna Verma; Shazia Shaheen Mir; Madhav Agarwal; Neeta Singh; Hemanta Kumar Kar; Vinod Kumar Sharma
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

3.  Estimating prevalence trends in adult gonorrhoea and syphilis in low- and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016.

Authors:  Eline L Korenromp; Guy Mahiané; Jane Rowley; Nico Nagelkerke; Laith Abu-Raddad; Francis Ndowa; Amina El-Kettani; Houssine El-Rhilani; Philippe Mayaud; R Matthew Chico; Carel Pretorius; Kendall Hecht; Teodora Wi
Journal:  Sex Transm Infect       Date:  2017-03-21       Impact factor: 3.519

4.  Trends in Adult Chlamydia and Gonorrhea Prevalence, Incidence and Urethral Discharge Case Reporting in Morocco over 1995-2015-Estimates Using the Spectrum-Sexually Transmitted Infection Model.

Authors:  Amina El-Kettani; Guy Mahiané; Aziza Bennani; Laith Abu-Raddad; Alex Smolak; Jane Rowley; Nico Nagelkerke; Houssine El-Rhilani; Kamal Alami; Amina Hançali; Eline Korenromp
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

5.  Genetic and Phenotypic Screening of Mannose-Binding Lectin in Relation to Risk of Recurrent Vulvovaginal Infections in Women of North India: A Prospective Cohort Study.

Authors:  Namarta Kalia; Jatinder Singh; Sujata Sharma; Hardesh Arora; Manpreet Kaur
Journal:  Front Microbiol       Date:  2017-01-31       Impact factor: 5.640

6.  Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.

Authors:  Eline L Korenromp; Teodora Wi; Stephen Resch; John Stover; Nathalie Broutet
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

Review 7.  The epidemiology of HIV infection in Morocco: systematic review and data synthesis.

Authors:  S P Kouyoumjian; G R Mumtaz; N Hilmi; A Zidouh; H El Rhilani; K Alami; A Bennani; E Gouws; P D Ghys; L J Abu-Raddad
Journal:  Int J STD AIDS       Date:  2013-07       Impact factor: 1.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.